Added by | André Pèlegrin |
---|---|
Group name | EquipeAP |
Item Type | Attachment |
Title | PubMed entry |
URL | http://www.ncbi.nlm.nih.gov/pubmed/32057646 |
Accessed | 2020/02/17 - 12:32:53 |
Date Added | 2020/02/17 - 11:32:53 |
Date Modified | 2020/02/17 - 11:32:53 |
Parent item | [Indications and outlooks of radiohormonal therapy of high-risk prostate cancers] |